4-aminobutyric acid

4-aminobutyric acid is a lipid of Fatty Acyls (FA) class. 4-aminobutyric acid is associated with abnormalities such as Epilepsy and Premenstrual syndrome. The involved functions are known as Binding (Molecular Function), neuron survival, Process, Uptake and physiological aspects. 4-aminobutyric acid often locates in Microglial, Neurofilament, Neuraxis, Brain region and Neurites. The associated genes with 4-aminobutyric acid are arginine methyl ester, SLC33A1 gene, NKS1 gene, P4HTM gene and ITSN2 gene. The related lipids are pregnenolone sulfate, pregnane-20-one, Pregnanes, Steroids and endogenous steroids.

Cross Reference

Introduction

To understand associated biological information of 4-aminobutyric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 4-aminobutyric acid?

4-aminobutyric acid is suspected in Premenstrual syndrome, Epilepsy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 4-aminobutyric acid

MeSH term MeSH ID Detail
Causalgia D002422 1 associated lipids
Polyradiculopathy D011128 1 associated lipids
Muscle Hypertonia D009122 1 associated lipids
Iatrogenic Disease D007049 1 associated lipids
Vision, Low D015354 1 associated lipids
Presbycusis D011304 1 associated lipids
Dandy-Walker Syndrome D003616 1 associated lipids
Hypernatremia D006955 1 associated lipids
Nelson Syndrome D009347 1 associated lipids
Gigantism D005877 1 associated lipids
Per page 10 20 50 100 | Total 280

PubChem Associated disorders and diseases

What pathways are associated with 4-aminobutyric acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 4-aminobutyric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 4-aminobutyric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 4-aminobutyric acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 4-aminobutyric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 4-aminobutyric acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 4-aminobutyric acid

Download all related citations
Per page 10 20 50 100 | Total 40318
Authors Title Published Journal PubMed Link
Herrero MT et al. Mechanism by which GABA, through its GABA(A) receptor, modulates glutamate release from rat cortical neurons in culture. 1999 Neurochem. Int. pmid:10213073
Judge S and Leitch B GABA immunoreactivity in processes presynaptic to the locust wing stretch receptor neuron. 1999 J. Comp. Neurol. pmid:10213191
Arndt CF et al. Outer retinal dysfunction in patients treated with vigabatrin. 1999 Neurology pmid:10214744
Papp EC et al. Medial septal and median raphe innervation of vasoactive intestinal polypeptide-containing interneurons in the hippocampus. 1999 Neuroscience pmid:10215142
Estevez AY et al. Effects of anion channel blockers on hyposmotically induced amino acid release from the in vivo rat cerebral cortex. 1999 Neurochem. Res. pmid:10215520
Rapallino MV et al. Stimulation of chloride in-->out permeation across the Deiters' neuron membrane by pentobarbital on the cytoplasmic side: additional evidence of GABA(A) receptors acting as chloride extrusion pumps. 1999 Neurochem. Res. pmid:10215521
Hu LA and King SC Identification of the amine-polyamine-choline transporter superfamily 'consensus amphipathic region' as the target for inactivation of the Escherichia coli GABA transporter GabP by thiol modification reagents. Role of Cys-300 in restoring thiol sensitivity to Gabp lacking Cys. 1999 Biochem. J. pmid:10215604
Xiong H et al. Mutual regulation between the intercellular messengers nitric oxide and brain-derived neurotrophic factor in rodent neocortical neurons. 1999 Eur. J. Neurosci. pmid:10215909
Ali AB et al. IPSPs elicited in CA1 pyramidal cells by putative basket cells in slices of adult rat hippocampus. 1999 Eur. J. Neurosci. pmid:10215927
Maruyama S and Kawasaki T Further electrophysiological evidence for the GABA-like effect of droperidol in the Purkinje cells of the cat cerebellum. 1976 Jpn. J. Pharmacol. pmid:1021614
Braga MF et al. Lead increases tetrodotoxin-insensitive spontaneous release of glutamate and GABA from hippocampal neurons. 1999 Brain Res. pmid:10216192
Braga MF et al. Nanomolar concentrations of lead inhibit glutamatergic and GABAergic transmission in hippocampal neurons. 1999 Brain Res. pmid:10216193
Jaliffa CO et al. Effect of GABA on melatonin content in golden hamster retina. 1999 J. Neurochem. pmid:10217277
Holt RA et al. Decreased GABA enhancement of benzodiazepine binding after a single dose of diazepam. 1999 J. Neurochem. pmid:10217306
Sanna E et al. Characterization of the electrophysiological and pharmacological effects of 4-iodo-2,6-diisopropylphenol, a propofol analogue devoid of sedative-anaesthetic properties. 1999 Br. J. Pharmacol. pmid:10217539
García Callejo FJ et al. [Use of gabapentin in glossopharyngeal neuralgia]. 1999 Acta Otorrinolaringol Esp pmid:10217696
Burrows KB and Meshul CK High-dose methamphetamine treatment alters presynaptic GABA and glutamate immunoreactivity. 1999 Neuroscience pmid:10218784
Fassio A et al. Evidence for calcium-dependent vesicular transmitter release insensitive to tetanus toxin and botulinum toxin type F. 1999 Neuroscience pmid:10218789
Rozzo A et al. Antagonism by (1,2,5,6-tetrahydropyridine-4-yl) methylphosphinic acid of synaptic transmission in the neonatal rat spinal cord in vitro: an electrophysiological study. 1999 Neuroscience pmid:10218807
Shen W et al. Pregnenolone sulfate and dehydroepiandrosterone sulfate inhibit GABA-gated chloride currents in Xenopus oocytes expressing picrotoxin-insensitive GABA(A) receptors. 1999 Neuropharmacology pmid:10218867
Melnick IV et al. Rat hippocampal neurons maintain their own GABAergic synaptic transmission in culture. 1999 Neurosci. Lett. pmid:10218878
Kaehler ST et al. Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus. 1999 Neurosci. Lett. pmid:10218890
Novotny EJ et al. GABA changes with vigabatrin in the developing human brain. 1999 Epilepsia pmid:10219272
Boyd RA et al. Effects of age and gender on single-dose pharmacokinetics of gabapentin. 1999 Epilepsia pmid:10219274
Pollák E and Molnár L Distribution of GABA-immunoreactive neurons in the terminal ganglion of the isopod Porcellio scaber. 1998 Neurobiology (Bp) pmid:10220781
Jelitai M et al. Non-synaptic effects of glutamic acid and GABA in cultures of developing neural cells. 1998 Neurobiology (Bp) pmid:10220788
Cabras PL et al. Clinical experience with gabapentin in patients with bipolar or schizoaffective disorder: results of an open-label study. 1999 J Clin Psychiatry pmid:10221286
Dahl-Jørgensen A et al. Serum and CNTF stimulate oligodendroglia and reduce fiber outgrowth from striatal cultures. 1999 Exp. Neurol. pmid:10222111
Schlösser B et al. Local disinhibition of neocortical neuronal circuits causes augmentation of glutamatergic and GABAergic synaptic transmission in the rat neostriatum in vitro. 1999 Exp. Neurol. pmid:10222121
Petroff OA et al. Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures. 1999 Seizure pmid:10222306
Terasawa E et al. An increase in glutamate release follows a decrease in gamma aminobutyric acid and the pubertal increase in luteinizing hormone releasing hormone release in the female rhesus monkeys. 1999 J. Neuroendocrinol. pmid:10223281
Gonzalo-Ruiz A et al. Localization of amino acids, neuropeptides and cholinergic neurotransmitter markers in identified projections from the mesencephalic tegmentum to the mammillary nuclei of the rat. 1999 J. Chem. Neuroanat. pmid:10223311
Telfeian AE et al. Lack of correlation between neuronal hyperexcitability and electrocorticographic responsiveness in epileptogenic human neocortex. 1999 J. Neurosurg. pmid:10223462
Sun B et al. [Effects of injection of GABA into lateral cerebroventricle on sleep-wakefulness of cats]. 1997 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:10223821
Kita H et al. In vivo and in vitro toxicodynamic analyses of new quinolone-and nonsteroidal anti-inflammatory drug-induced effects on the central nervous system. 1999 Antimicrob. Agents Chemother. pmid:10223919
Tarakanov IA et al. [Sensitivity of the respiratory system to lung mechanoreceptor impulses during GABAergic system activation]. 1999 Biull Eksp Biol Med pmid:10225094
Chuppina LM [Chemical heterogenicity of the synaptic organization of different regions of the rabbit cerebral cortex]. 1976 Fiziol Zh SSSR Im I M Sechenova pmid:1022528
Richter A and Löscher W Gabapentin decreases the severity of dystonia at low doses in a genetic animal model of paroxysmal dystonic choreoathetosis. 1999 Eur. J. Pharmacol. pmid:10225372
Podell M and Hadjiconstantinou M Low concentrations of cerebrospinal fluid GABA correlate to a reduced response to phenobarbital therapy in primary canine epilepsy. 1999 Mar-Apr J. Vet. Intern. Med. pmid:10225597
Dupuy-Davies S and Houser CR Evidence for changing positions of GABA neurons in the developing rat dentate gyrus. 1999 Hippocampus pmid:10226778
Tian J et al. GABA(A) receptors mediate inhibition of T cell responses. 1999 J. Neuroimmunol. pmid:10227421
Jezyk N et al. Transport of pregabalin in rat intestine and Caco-2 monolayers. 1999 Pharm. Res. pmid:10227706
Colado MI et al. Studies on the neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration. 1999 Psychopharmacology (Berl.) pmid:10229068
Pollák E et al. Localization and source of gamma aminobutyric acid immunoreactivity in the isthmic nucleus of the frog Rana esculenta. 1999 Brain Res. Bull. pmid:10229344
Caviedes BE et al. [In children with refractory epilepsy: vigabatrin or lamotrigine?]. 1999 Mar 1-15 Rev Neurol pmid:10229954
Baek NI et al. Isolation and identification of succinic semialdehyde dehydrogenase inhibitory compound from the rhizome of Gastrodia elata Blume. 1999 Arch. Pharm. Res. pmid:10230516
Calogero AE et al. Gamma-aminobutyric acid (GABA) A and B receptors mediate the stimulatory effects of GABA on the human sperm acrosome reaction: interaction with progesterone. 1999 Fertil. Steril. pmid:10231059
Parsons LH et al. RU 24969, a 5-HT1B/1A receptor agonist, potentiates cocaine-induced increases in nucleus accumbens dopamine. 1999 Synapse pmid:10231132
Rocha L et al. Gabapentin modifies extracellular opioid peptide content in amygdala: a microdialysis study. 1999 Epilepsy Res. pmid:10232790
Gobbi G et al. Prospective study of first-line vigabatrin monotherapy in childhood partial epilepsies. 1999 Epilepsy Res. pmid:10232792